In this upcoming live webinar, experts will explain how insulin resistance, chronic inflammation, and adipose tissue dysfunction contribute to hepatic steatosis and MASLD progression.
Learn more about the metabolic dysfunction related to MASLD: https://t.co/QbJEzJ9Fhn
#MASLD #MetabolicDysfunction #Obesity #Hepatology #Healthcare
Dr. Robyn Pashby, a speaker at @ObesityWeek 2026, provides her perspective on the role of body positivity in obesity care.
Thank you to @ObesitySociety for having us. We’re excited to see what next year’s conference has in store! #ObesityWeek#OW2026
Tomorrow: Tune in to explore the evolving role of TROP2-directed ADCs following TKI therapy in EGFR-mutated advanced NSCLC.
Join expert faculty for practical perspectives on treatment sequencing, patient selection, and toxicity monitoring and management.
Last chance to participate in the live webinar series: https://t.co/oYxylibZ91
A CME/CE-accredited activity developed by GLC.
#NSCLC #LungCancer #ThoracicOncology #Oncology #CancerEducation #MedicalEducation
From @ObesityWeek 2026, Dr. John Morton shares insights on the future of multidisciplinary obesity care.
More to come from the conference, hosted by @ObesitySociety! #ObesityWeek#ow2026
How can evidence inform treatment decisions in post-platinum ES-SCLC?
Join Drs. @StephenVLiu, Karthik Suresh, and Christine Hann an interactive, case-based symposium. These experts will explore patient selection, treatment sequencing, CNS activity, and ILD management with B7-H3-directed ADCs.
Register: https://t.co/fYVAZPxtzh
A CME/CE-accredited activity developed by GLC.
#ESSCLC #LungCancer #MedEd
FDA-approved treatment options for pediatric patients with FSGS represent an important advancement in kidney care.
Explore the significance of this indication and what it means for younger patients: https://t.co/1jORxBumaM
#FSGS#Nephrology#KidneyHealth
Our upcoming live breakfast symposium is just two days away!
Join expert faculty for a case-based discussion on obesity treatment success beyond percent weight loss.
Reserve your place: https://t.co/htLI8k3942
#CME#ObesityWeek#ObesityWeek2026
Three weeks until WHAV 2026 in New York.
On December 4, join co-chairs Barbara Dehn, NP and Anita L. Nelson, MD at the Sheraton New York Times Square Hotel for a full day of practical, evidence-based women’s health education.
Register now: https://t.co/m5FAEXexFH
#WHAV2026 #WomensHealth #MedicalEducation #CME #NYC
This upcoming live broadcast will explore the multifaceted management of obesity and MASLD, including the importance of addressing hepatic fat accumulation and early assessment for MASLD.
Don’t miss out—register now: https://t.co/Gz6LKW0Uxz
#Obesity#MASLD#LifestyleMedicine #MetabolicHealth #MedicalEducation
WHAV 2026 is tomorrow! Join us at the Pasadena Convention Center, or tune in to the live broadcast online: https://t.co/oL4HVjV5n0 #WHAV2026#WomensHealth#Pasadena
How are cereblon E3 ligase modulators (CELMoDs) influencing treatment strategies for relapsed/refractory multiple myeloma?
Join expert faculty as they examine the biologic rationale behind CELMoDs, review emerging clinical data supporting combination regimens, and discuss how these agents can be sequenced alongside T-cell–redirecting therapies. The symposium also explores practical approaches to managing hematologic toxicities and incorporating serial minimal residual disease assessment into treatment decisions.
Explore the latest evidence: https://t.co/CuEmjLcL55
A CME/CE-accredited activity developed by GLC.
#MultipleMyeloma #Hematology #ASH #MedEd
As treatment options continue to evolve for EGFR-mutated advanced NSCLC, where do TROP2-directed ADCs fit into the post-TKI treatment landscape?
Hear expert faculty discuss emerging clinical evidence, evolving treatment sequencing considerations, and practical strategies for integrating TROP2-directed ADCs into clinical practice. Through interactive case discussions, participants will also explore approaches to identifying appropriate candidates and proactively monitoring and managing class-specific toxicities.
Participate in this live webinar series to gain practical insights that can help inform personalized treatment planning:
https://t.co/rDsPwqbCQY
A CME/CE-accredited activity developed by GLC.
#NSCLC #LungCancer #ThoracicOncology #Oncology #CancerEducation #MedicalEducation
Just under one week until our live breakfast symposium on the quality of #WeightLoss. Explore interactive cases on muscle health, residual #CardiovascularRisk, and treatment success beyond the scale. Register here: https://t.co/8K8pxPHskw
#Obesity#Endocrinology#ObesityWeek #ObesityWeek2026 A CME/CE-accredited activity developed by GLC
This upcoming live webinar will review the mechanisms linking adipose tissue dysfunction to hepatic steatosis and fibrosis, while examining practical approaches to identifying patients who may benefit from MASLD evaluation.
Find a broadcast that fits your schedule: https://t.co/Lcm8eUmtdi
#MASLD #Obesity #MetabolicDysfunction #Hepatology
CME Dinner Tomorrow. Which path will YOU choose?
Join us in Philadelphia for an interactive Choose Your Own Adventure™ CME dinner symposium. Vote LIVE as expert faculty guide you through real-world patient cases, evolving treatment options, and critical decisions that shape TED care.
Don't miss this unique CME experience!
Register for the in-person event or virtual broadcast: https://t.co/x670ZGqQNm
A CME/CE-accredited activity developed by GLC.
#TED #ThyroidEyeDisease #MedEd #CME
WHAV 2026 is coming to New York in one month.
Join us December 4 at the Sheraton New York Times Square Hotel for the Women’s Health Annual Visit, a full day of expert-led, evidence-based education from world-renowned faculty and clinicians.
Save your seat today: https://t.co/7DEfRFVl34
#WHAV2026 #WomensHealth #MedicalEducation #CME #NYC
How do age and body weight influence sparsentan dosing in patients with FSGS?
Hear an expert explain the weight-based starting doses and titration considerations for eligible patients aged 8 years and older.
Check out the full program: https://t.co/qO7t8ma5bv
#FSGS#Nephrology #Sparsentan #MedicalEducation
First-line treatment of KRAS G12C-mutated NSCLC is evolving. Is your practice keeping pace?
Join Timothy F. Burns, MD, PhD, thoracic oncologist and lung cancer researcher at the Ohio State University Comprehensive Cancer Center, LIVE for "Closing the Gap in First-Line Treatment of KRAS G12C–Mutated Advanced NSCLC: From Biology to Bedside Decisions and Trial-Ready Care."
📅 November 9, 2026
🕕 7:00–7:45 PM EDT
Dr. Burns will connect the underlying biology of KRAS G12C–mutated advanced NSCLC to real clinical decision-making, giving you a clear framework to apply in first-line treatment.
Register for the virtual broadcast now: https://t.co/InlJPp3LQA
A CME/CE-accredited activity developed by GLC.
#LungCancer #NSCLC #MedEd
This upcoming live broadcast will explore how metabolic dysfunction links to obesity and MASLD, highlighting how excess visceral fat contributes to MASLD progression and increased cardiometabolic risk.
Register now: https://t.co/f0yLu6gdGB
#Obesity#MASLD#MetabolicHealth #MedicalEducation